Skip to content

Clinical trials

Completed Myelodysplastic Syndromes trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Status: Completed Country / region: South Korea Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20051
20082
20094
20102
20113
20121
20132
20142
20163
20172
20181
20191
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center7
Novartis Pharmaceuticals5
Celgene3
GlaxoSmithKline2
Samsung Medical Center2
Seoul National University Hospital2
Astex Pharmaceuticals, Inc.1
Cooperative Study Group A for Hematology1
Forma Therapeutics, Inc.1
JW Pharmaceutical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes30
Leukemia, Myeloid, Acute14
Leukemia, Myelomonocytic, Chronic10
Leukemia7
Anemia, Refractory, with Excess of Blasts4
Blast Crisis4
Leukemia, Myeloid, Accelerated Phase4
Leukemia, Myeloid, Chronic-Phase4
Lymphoma4
Lymphoma, Mantle-Cell4

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.